To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
Clinical trial NCT00430716 · TERMINATED
Trial details
- NCT number
- NCT00430716
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-08
- Primary completion
- 2010-05-25
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.